Cargando…
Interleukin-17A and B-cell activating factor in chronic hepatitis C patients with or without asymptomatic mixed cryoglobulinemia: effects of antiviral treatment and correlations with vitamin D
BACKGROUND: Several studies have provided conflicting results regarding the immune responses in chronic hepatitis C (CHC) patients with mixed cryoglobulinemia (MC). The importance of B-cell activating factor (BAFF) in MC has been described, but the role of interleukin (IL)-17A is less clear. METHODS...
Autores principales: | Konstantinides, Polydoros, Alexopoulou, Alexandra, Hadziyannis, Emilia, Kanellopoulou, Theoni, Dourakis, Spyridon P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hellenic Society of Gastroenterology
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6191865/ https://www.ncbi.nlm.nih.gov/pubmed/30386121 http://dx.doi.org/10.20524/aog.2018.0310 |
Ejemplares similares
-
The significance of platelet microparticles in patients with chronic hepatitis C and their association with antiviral treatment and smoking
por: Kanellopoulou, Theoni, et al.
Publicado: (2016) -
Mixed cryoglobulinemia
por: Ferri, Clodoveo
Publicado: (2008) -
Q fever endocarditis masquerading as Mixed cryoglobulinemia type II. A case report and review of the literature
por: Rafailidis, Petros I, et al.
Publicado: (2006) -
Development of non-Hodgkin’s lymphoma in a patient with primary biliary cirrhosis: A case report and review of the literature
por: Kanellopoulou, Theoni, et al.
Publicado: (2011) -
Rheumatoid Factor, Complement, and Mixed Cryoglobulinemia
por: Gorevic, Peter D.
Publicado: (2012)